These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21369941)

  • 21. Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer.
    Liang JZ; Li YH; Zhang Y; Wu QN; Wu QL
    Int J Clin Exp Pathol; 2015; 8(3):2937-45. PubMed ID: 26045802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.
    Ludovini V; Bellezza G; Pistola L; Bianconi F; Di Carlo L; Sidoni A; Semeraro A; Del Sordo R; Tofanetti FR; Mameli MG; Daddi G; Cavaliere A; Tonato M; Crinò L
    Ann Oncol; 2009 May; 20(5):842-9. PubMed ID: 19153117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW; Wang TB; Tian YH; Zheng YG
    Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
    Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S
    PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.
    Yin X; Xia J; Sun Y; Zhang Z
    BMC Pulm Med; 2020 Feb; 20(1):40. PubMed ID: 32054470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
    Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
    Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer.
    Xiong Q; Fan S; Duan L; Liu B; Jiang X; Chen X; Xiong C; Tao Q; Wang J; Zhang H; Chen C; Duan Y
    Mol Med Rep; 2020 Oct; 22(4):2916-2924. PubMed ID: 32945371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
    Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
    Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
    Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
    Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of 14-3-3γ overexpression in advanced non-small cell lung cancer.
    Raungrut P; Wongkotsila A; Lirdprapamongkol K; Svasti J; Geater SL; Phukaoloun M; Suwiwat S; Thongsuksai P
    Asian Pac J Cancer Prev; 2014; 15(8):3513-8. PubMed ID: 24870749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.
    Wang X; Du Z; Li L; Shi M; Yu Y
    Int J Clin Exp Pathol; 2015; 8(9):10644-52. PubMed ID: 26617774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
    Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
    J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
    Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
    Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.